205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.48%
Revenue growth below 50% of MRVL's 4.29%. Michael Burry would check for competitive disadvantage risks.
No Data
No Data available this quarter, please select a different quarter.
1.48%
Gross profit growth below 50% of MRVL's 3.82%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.48%
Other expenses change of 1.48% while MRVL maintains costs. Bruce Berkowitz would investigate efficiency.
1.48%
Operating expenses growth while MRVL reduces costs. John Neff would investigate differences.
1.48%
Total costs growth 50-75% of MRVL's 2.65%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-419.62%
EBITDA decline while MRVL shows 4.17% growth. Joel Greenblatt would examine position.
-414.97%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-419.62%
Operating income decline while MRVL shows 15.99% growth. Joel Greenblatt would examine position.
-414.97%
Operating margin decline while MRVL shows 5.31% growth. Joel Greenblatt would examine position.
419.62%
Other expenses growth while MRVL reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
50.36%
Net income growth while MRVL declines. John Neff would investigate advantages.
51.09%
Net margin growth while MRVL declines. John Neff would investigate advantages.
57.14%
EPS growth while MRVL declines. John Neff would investigate advantages.
57.14%
Diluted EPS growth while MRVL declines. John Neff would investigate advantages.
0.56%
Share count increase while MRVL reduces shares. John Neff would investigate differences.
0.56%
Diluted share reduction exceeding 1.5x MRVL's 1.17%. David Dodd would verify capital allocation.